Stock Quotes & Company News | Reuters.com
Edition:
United States

People: AstraZeneca PLC (AZN.L)

AZN.L on London Stock Exchange

4,502.50GBp
12:07pm EDT
Change (% chg)

35.50p (+0.80%)
Prev Close
4,467.00p
Open
4,467.00p
Day's High
4,513.00p
Day's Low
4,394.00p
Volume
3,284,482
Avg. Vol
2,722,194
52-wk High
4,634.00p
52-wk Low
3,680.00p

Dunoyer, Marc 

Mr. Marc Dunoyer has been appointed as Chief Financial Officer, Executive Director of AstraZeneca PLC, effective 1 November 2013. His career in pharmaceuticals, which has included periods with Roussel Uclaf, Hoechst Marion Roussel and GlaxoSmithKline (GSK), has given him extensive industry experience, including finance and accounting; corporate strategy and planning; research and development; sales and marketing; business reorganisation; and business development. Marc qualified as an accountant and joined AstraZeneca in 2013, serving as Executive Vice-President, GPPS from June to October 2013. Prior to that, he served as Global Head of Rare Diseases at GSK and (concurrently) Chairman, GSK Japan. He holds an MBA from HEC, Paris and a Bachelor of Law degree from Paris University.

Basic Compensation

Total Annual Compensation, GBP 1,696,000
Restricted Stock Awards, GBP --
Long-Term Incentive Plans, GBP --
All Other, GBP 225,000
Fiscal Year Total, GBP 1,921,000

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --